Marrone Bio Innovations (NASDAQ:MBII) Issues Earnings Results, Misses Expectations By $0.02 EPS

Marrone Bio Innovations (NASDAQ:MBII – Get Rating) released its earnings results on Wednesday. The basic materials company reported ($0.04) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02), MarketWatch Earnings reports. Marrone Bio Innovations had a negative return on equity of 65.95% and a negative net margin of 47.07%. During […]

Related Keywords

United States ,America ,Pamelag Marrone , ,Securities Exchange Commission ,Marrone Bio Innovations Inc ,Goldman Sachs Group Inc ,Marrone Bio Innovations Company Profile Get Rating ,Virtu Financial ,Zacks Investment Research ,America Corp ,Nasdaq ,Wells Fargo Company ,Canaccord Genuity Group ,Citadel Advisors ,Marrone Bio Innovations ,Get Rating ,Marketwatch Earnings ,Bio Innovations ,Director Pamela ,Exchange Commission ,Sachs Group ,Investment Research ,Genuity Group ,Bio Innovations Company Profile ,Nasdaq Mbii ,Imbii ,Basic Material ,Earnings ,